Head-to-head · WeighScore
Eden vs Joey Med
The verdict
Eden takes it — 81.6/100 to 53.9/100.
Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. High-disclosure, high-oversight compounded program with the cleanest verification signals.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eden | Joey Med |
|---|---|---|
| WeighScore | 81.6/100 | 53.9/100 |
| Grade | B− | C |
| Site position | #16 | #508 |
| Semaglutide | $239/mo | $279/mo (compounded) |
| Tirzepatide | $349/mo | $399/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #16 · B−
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Strengths
- High verification confidence
- Nationwide
- Both molecules
Where it loses points
- Premium pricing
- Compounded only
Site position #508 · C
Strengths
- Three GLP-1 tiers listed with dual pricing on the products page
- Ships to all 50 states
- Refund and cancellation policy publicly linked
- Tampa, FL location anchor provides a geographic identifier
- Lets patients consolidate weight loss with ED, hair, and longevity treatments
Where it loses points
- Drug names (semaglutide vs tirzepatide) not disclosed — products sold as 'GLP-1 Core / Plus / High Dose'
- Compounded vs brand-name not stated (appears compounded but unconfirmed)
- 503A vs 503B designation not specified
- Pharmacy partner not named
- No LegitScript certification mentioned
Featured provider
Eden
Eden scores 81.6/100 (B−). High-disclosure, high-oversight compounded program with the cleanest verification signals.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.